Page last updated: 2024-08-24

lamivudine and Opportunistic Infections

lamivudine has been researched along with Opportunistic Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chim, B; Choun, K; Lorent, N; Lynen, L; Thai, S; van Griensven, J1
Akdogan, A; Bayraktar, Y; Bilgen, SA; Calguneri, M; Ersoy, O; Ertenli, I; Kalyoncu, U; Karadag, O; Kiraz, S; Yonem, O1
Lim, Z; Moses, SE; Zuckerman, MA1
Goliath, R; Meintjes, G; Seldon, R; Wilkinson, KA; Wilkinson, RJ1
Gillis, S; Hubert, A; Ilan, Y; Safadi, R; Shibolet, O; Shouval, D1

Reviews

1 review(s) available for lamivudine and Opportunistic Infections

ArticleYear
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:10

    Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Management; DNA, Viral; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Immunosuppression Therapy; Lamivudine; Opportunistic Infections; Transplantation Conditioning; Virus Activation; Virus Replication

2011

Trials

1 trial(s) available for lamivudine and Opportunistic Infections

ArticleYear
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Treatment Outcome; Virus Activation

2002

Other Studies

3 other study(ies) available for lamivudine and Opportunistic Infections

ArticleYear
Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
    Tropical medicine & international health : TM & IH, 2015, Volume: 20, Issue:12

    Topics: Adult; Ambulatory Care Facilities; Anti-HIV Agents; Antitubercular Agents; Cambodia; Drug Interactions; Female; HIV; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Nevirapine; Opportunistic Infections; Patient Dropouts; Retrospective Studies; Stavudine; Tuberculosis

2015
Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.
    Rheumatology international, 2009, Volume: 29, Issue:7

    Topics: Adult; Aged; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Viral Load

2009
Immunological characterisation of an unmasking TB-IRIS case.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012, Mar-02, Volume: 102, Issue:6

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Cytokines; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Opportunistic Infections; Stavudine; Thymic Factor, Circulating; Tuberculosis, Pulmonary

2012